Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subhendu Karmakar

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Dalton Transactions (Cambridge, England : 2003)|January 11, 2019
Modulation of the reactivity of nitrogen mustards by metal complexation: approaches to modify their therapeutic propertiesSubhendu Karmakar, Moumita Maji, Arindam Mukherjee
Dalton Transactions (Cambridge, England : 2003)|January 27, 2016
Anticancer activity of a cis-dichloridoplatinum(ii) complex of a chelating nitrogen mustard: insight into unusual guanine binding mode and low deactivation by glutathioneSubhendu Karmakar, Kallol Purkait, Saptarshi Chatterjee, et al.
Journal of Inorganic Biochemistry|January 9, 2020
A trans-dichloridoplatinum(II) complex of a monodentate nitrogen mustard: Synthesis, stability and cytotoxicity studiesSubhendu Karmakar, Saptarshi Chatterjee, Kallol Purkait, et al.
Dalton Transactions (Cambridge, England : 2003)|May 28, 2016
Anticancer activity of a chelating nitrogen mustard bearing tetrachloridoplatinum(iv) complex: better stability yet equipotent to the Pt(ii) analogueSubhendu Karmakar, Saptarshi Chatterjee, Kallol Purkait, et al.
Dalton Transactions (Cambridge, England : 2003)|April 28, 2016
Alteration of steric hindrance modulates glutathione resistance and cytotoxicity of three structurally related Ru(II)-p-cymene complexesKallol Purkait, Saptarshi Chatterjee, Subhendu Karmakar, et al.
Dalton Transactions (Cambridge, England : 2003)|February 6, 2020
Oxamusplatin: a cytotoxic Pt(ii) complex of a nitrogen mustard with resistance to thiol based sequestration displays enhanced selectivity towards cancerMoumita Maji, Subhendu Karmakar, Ruturaj, et al.
Inorganic Chemistry|March 25, 2020
Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive MoleculesTomer Babu, Amrita Sarkar, Subhendu Karmakar, et al.
Inorganic Chemistry|December 3, 2019
Synthesis and Cytotoxicity of Water-Soluble Dual- and Triple-Action Satraplatin Derivatives: Replacement of Equatorial Chlorides of Satraplatin by AcetatesSubhendu Karmakar, Isabella Poetsch, Christian R Kowol, et al.
Journal of Medicinal Chemistry|November 11, 2020
Platinum(IV)-Estramustine Multiaction Prodrugs Are Effective Antiproliferative Agents against Prostate Cancer CellsSubhendu Karmakar, Hana Kostrhunova, Tereza Ctvrtlikova, et al.
Dalton Transactions (Cambridge, England : 2003)|March 6, 2015
A hypoxia efficient imidazole-based Ru(II) arene anticancer agent resistant to deactivation by glutathioneKallol Purkait, Subhendu Karmakar, Sudipta Bhattacharyya, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Dalton Transactions (Cambridge, England : 2003)|January 11, 2019
Modulation of the reactivity of nitrogen mustards by metal complexation: approaches to modify their therapeutic propertiesSubhendu Karmakar, Moumita Maji, Arindam Mukherjee
Dalton Transactions (Cambridge, England : 2003)|January 27, 2016
Anticancer activity of a cis-dichloridoplatinum(ii) complex of a chelating nitrogen mustard: insight into unusual guanine binding mode and low deactivation by glutathioneSubhendu Karmakar, Kallol Purkait, Saptarshi Chatterjee, et al.
Journal of Inorganic Biochemistry|January 9, 2020
A trans-dichloridoplatinum(II) complex of a monodentate nitrogen mustard: Synthesis, stability and cytotoxicity studiesSubhendu Karmakar, Saptarshi Chatterjee, Kallol Purkait, et al.
Dalton Transactions (Cambridge, England : 2003)|May 28, 2016
Anticancer activity of a chelating nitrogen mustard bearing tetrachloridoplatinum(iv) complex: better stability yet equipotent to the Pt(ii) analogueSubhendu Karmakar, Saptarshi Chatterjee, Kallol Purkait, et al.
Dalton Transactions (Cambridge, England : 2003)|April 28, 2016
Alteration of steric hindrance modulates glutathione resistance and cytotoxicity of three structurally related Ru(II)-p-cymene complexesKallol Purkait, Saptarshi Chatterjee, Subhendu Karmakar, et al.
Dalton Transactions (Cambridge, England : 2003)|February 6, 2020
Oxamusplatin: a cytotoxic Pt(ii) complex of a nitrogen mustard with resistance to thiol based sequestration displays enhanced selectivity towards cancerMoumita Maji, Subhendu Karmakar, Ruturaj, et al.
Inorganic Chemistry|March 25, 2020
Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive MoleculesTomer Babu, Amrita Sarkar, Subhendu Karmakar, et al.
Inorganic Chemistry|December 3, 2019
Synthesis and Cytotoxicity of Water-Soluble Dual- and Triple-Action Satraplatin Derivatives: Replacement of Equatorial Chlorides of Satraplatin by AcetatesSubhendu Karmakar, Isabella Poetsch, Christian R Kowol, et al.
Journal of Medicinal Chemistry|November 11, 2020
Platinum(IV)-Estramustine Multiaction Prodrugs Are Effective Antiproliferative Agents against Prostate Cancer CellsSubhendu Karmakar, Hana Kostrhunova, Tereza Ctvrtlikova, et al.
Dalton Transactions (Cambridge, England : 2003)|March 6, 2015
A hypoxia efficient imidazole-based Ru(II) arene anticancer agent resistant to deactivation by glutathioneKallol Purkait, Subhendu Karmakar, Sudipta Bhattacharyya, et al.
Pageof 2